awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35905878-49F12885-8F0B-41BC-88C5-CA582B8AC79C
Q35905878-49F12885-8F0B-41BC-88C5-CA582B8AC79C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35905878-49F12885-8F0B-41BC-88C5-CA582B8AC79C
Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial.
P2860
Q35905878-49F12885-8F0B-41BC-88C5-CA582B8AC79C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35905878-49F12885-8F0B-41BC-88C5-CA582B8AC79C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4fe6e711407535158545936ad9dc0cfa60ac61b0
P2860
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.